Mexico: Biotechnology at Third Stage of Development

Last Updated: 17 January 2005

By Daniel Barrón Pastor

Biotechnology is modifying the cultural and economic relations within societies in the globalized world. Treatments and new drugs, genetically modified foods, materials, biologically controlled production processes, and many other applications, may well become part of our everyday lives improving health, agricultural, industrial, and energy production, affecting our societies as profoundly as oil or information technologies have already done.

Moreover, the knowledge of biological topics is modifying every ideology, language and conscience of humankind. The generation of disciplines such as ecology, sustainable development, biophilosophy, bioeconomy, as well as public discussion about cloning, genetically modified organisms, bioterrorism and the technological fear that involves each subject, show that life sciences are part of a major change in the conscience and perception of societies.

The cultural and economic transformations that arise from the life sciences allow to think about them as a major industrial revolution. Thus, if biotechnology shares the behavior of other industrial revolution phenomena of modern society (automobiles-or internal combustion motors, plastics, computers, etc.), then biotechnology be in a generational cycle that will span over 50 years.1

Until this moment, biotech is showing a development behavior that shares a lot of similarities with other industrial revolution generational cycles: In the first stage, the foundations of research methodologies which change how we study the subject (the biotech cycle could begin in the late 70’s and early 80’s, when we found the recombinant DNA and hybridome technologies, which change how we study biology). The second stage shows a lot of research methodologies but few discoveries that became products. The third stage is marked by a flow of innovative products derived from the new methodologies. In the fourth stage the products became incorporated into daily life, and in the final stage companies and products became fully integrated into the science research and the retail sectors of society.2

It is necessary to point out that the development of each stage is gradual and that the frontiers between them are not marked by a specific kind of event. As well, the appearance of events of a stage does not involve that events of the prior one have ended or that events of other one have appeared. Therefore, we can observe that biotech’s generational cycle is in the midst of the third stage and that there are some signs that involve the second and fourth stage.

The second stage events of the biotech’s generational cycle (a lot of research methodologies but few discoveries that became products) could be observed in the late 80’s and 90’s, specifically in the input of DNA sequences into databases (genes, genomes), the identification of function and participation in the cell and organisms physiology and the appearance of a generation of products evolved from this technologies (e.g. genetically modified crops, antibiotics, hormones etc. produced by modified microorganisms, water purification systems and new therapeutic methods and drugs). At this stage, investments were focused in research and development activities in basic research and the search/discovery of new molecular entities.

The third stage of the biotech’s generational cycle is marked by an increased flow of innovative products. This evolvement will be clearly observed in the increment of patent applications being submitted in the biotech’s category, when compared with prior years. Also, the third stage can be observed in the market wherein a large quantity of new biotechnological products are emerging.

This increased flow of products is not casual. Investors seem to be more risk conscious than in the 90’s decade, because the genomic and proteomic knowledge produced at the 90’s decade is evolving into products and, at the same time, the investors perception about research in these topics is that they need to become the high risk of the investments and a frustration feeling in terms of profits.

In this sense, Roger Longman at the 22nd JP Morgan Healthcare Conference said that "new molecular entity discovery has become so difficult to predict and localize that it may not be sensible to invest at the rates we have in the past" 3. Thus, the risks are higher in terms of the lower probability of discovery and the larger amount of capital needed for research. Also, he states that investment strategies are flowing from the risky research programs to the more secure late stages of product development:

"statistically, the drug industry and financial markets are paying therecognition of value, not new molecular entity discovery".

This change in the investment ideology is causing biotech companies to reorganize, cut back on their research programs and execute a business strategy of in-licensing products that are already in clinical development.

"To maintain anything close to traditional margins, drug developers must learn to explore the entire Research & development value chain for innovation, Longman said ‘the business development function in a company has become as important—if not more so— than the discovery function.’" 4

So, at this third stage of the cycle, the biotech industry is modifying the R&D activities in order to be more attractive to the investors, and the products derived from said new investments are signs of the incoming fourth stage of the biotech’s generational cycle.

Societies have also been modified but changes are less clear than those at industrial modifications. In the second half of the XXth century, the general attitude to life sciences advances was of surprise about knowledge, great expectations about, new medicine, caution about ecology problems, and ignorance translated in technologic fear. Therefore, the biotech industry and the nations have invested a lot of money in education, divulgation and media programs trying to keep the positive attitudes and trying to modify the bad ones. The objectives of these programs could be resumed as 1) keeping surprises that help in the development of the expectations, and 2) attacking ignorance and technologic fear.

Therefore, the impact of education programs in societies has been such way that ideologies, languages and disciplines have more terms and metaphors related to life sciences than ever in history. However, the attitudes of the ???public toward biotech seem to be the predominant until now,only that the public has much more information.

About consumers and public expectations, at this third stage of the biotech industrial revolution, the new drugs and treatments are being well accepted; the public has great expectations about the new medicine that would arise from the advances in the understanding of the human genome gene therapy and stem cells; consumers still have great confusion about ecologic and health risks related to genetically modified food and the new materials and industrial processes are quite known.

From all the above biotech industry wants to develop the local markets by introducing the new products through the public’s daily life needs and publicity, and wants to try –together with the national governments- to improve better local programs of education, divulgation, and research, in order to induce the nations to become societies of consumers (and developers5) of biotechnological products.

The introduction of new products when government and industry invest in local science development, could cause that the local communities tend to be better informed and therefore avoid adverse reactions in the acceptance of local markets caused by technologic fear.

Finally, the third stage of the biotechnology revolution is a complex challenge wherein the industry, the governments and the societies of the globalized world are being modified in order to survive to the biotech century.

Footnotes

1. "This cycles are part of the possible causes of long waves or long cycles of the world economy, also known as Kondratiev cycles. This cycles were known through empiric studies wherein the price tendency statistics, the interest rate and the market. Now, the economic variables related with the long waves are: 1) the technology advance and innovation (Shumpeter, Mensh and Kleinknecht); 2) the capital’s transformation and its impact in the different stages (Mandel and Forrester); 3) the effect of the long waves over the employment (Freeman); 4) the prime matter as a central variable (Rostow); 5) institutional and social modifications (Freeman, Pérez and Dosi). However, the long waves are a difficult to quantify phenomena because, in part, to the inconsistence and amplitude of the disposable statistical series." Paragraph taken from Leonel Corona Treviño, Technology, innovation and economical cycles, in Economical theories of technology, jus, CIECAS and IPN, Mexico 1999; page 130.

2. John F. Wong, Is biotech in the midst of a fifty year cycle? Genetic Engineering News –www.genengnews.com; March 1, 2005, vol 25, no. 5. Referring to interview with Nola Masterson, Ph.D.,. (Science Futures –San Francisco)

3. Roger Longman is the Managing Director of Windhover Information, Inc., and editor of In vivo: The business and Medicine report. Text from Lorraine Ruff and David Gabrilska, 22nd JPMorgan Annual Healthcare Conference Report, There’s is gold in tem that molecular tailings. July 22, 2005. http://www.iowatech.com/jpmorgan/drug_trends_04.htm??p1

4. Roger Longman, Ibidem.

5. Developing research and production systems in developed countries will reduce costs of research, development and production, causing the construction of a strong moral-scientist leadership at reduced costs. Therefore, at this third stage of the biotech industrial revolution, profitable solutions for the industry, investors and societies, will arise when the developing countries do more –—or have more investment— in research and development.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

 
Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.